indiafinancenews.com
‘Rs 150/dose non-competitive price, not sustainable’: Bharat Biotech defends higher pricing of Covaxin – Times of India
HYDERABAD: Amid heated debates about Covaxin being the most expensive Covid-19 vaccine in the private market at a price cap of Rs 1,410 per dose despite being indigenously developed, its developer …